Publicidad

Viabilidad miocárdica y SPECT de perfusión con 99mTc-MIBI: acerca de dos casos clínicos

Referencias

  1. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-3.
  2. Bonow R. Myocardial viability and prognosis in patients with left ventricular dysfunction. JACC 2002;39:1159-62.
  3. Rambaldi R, Polderman D. Dobutamine stress echocardiography and Technetium-99m-Tetrofosmin/Fluorine18-Fluorodeoxyglucose Single-Photon Emission Computed Tomography and influence of resting ejection fraction to assess myocardial viabi
  4. Allman K, Shaw L, et al Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151–8.
  5. Beller GA. Noninvasive assessment of myocardial viability. N Engl J Med 2000;343:1488–90.
  6. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
  7. Romero-Farina G et al. Efecto de la revascularización en la miocardiopatía isquémica con viabilidad en la gated-SPECT de perfusión miocárdica. Rev Esp Cardiol 2008;61:540-4.
  8. Vanoverschelde JL, Gerber B. Physiologic and metabolic basis of myocardial viability imaging. Chap 31 in Clinical Nuclear Cardiology. 3rd edition, 2005. Elsevier.